Is Tilray Stock A Buy As Senators Unveil Draft Legislation?

18
3
Favorite

Is Tilray Stock A Buy As Senators Unveil Draft Legislation?

investors2021-07-15

Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（3）

chichi000
·2021-07-15
Done
Reply
Like
Report
AventadorKK
·2021-07-15
Done
Reply
1
Report
Holla
·2021-07-15
Like my comment pls
Reply
1
Report
Fold Replies
- Stormdust23:
  Hi
  2021-07-15
  Reply
  Report
- AventadorKK:
  done
  2021-07-15
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1193186975?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-07-15 14:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193186975","market":"us","top_or_hot":-1,"title":"Is Tilray Stock A Buy As Senators Unveil Draft Legislation?","media":"investors","content":"<div>\n<p>Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should ...</p>\n\n<a href=\"https://www.investors.com/research/tilray-stock-buy-now/?src=A00220\">Source Link</a>\n\n</div>\n","source":"lsy1610449120050","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Tilray Stock A Buy As Senators Unveil Draft Legislation?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Tilray Stock A Buy As Senators Unveil Draft Legislation?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-15 14:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/research/tilray-stock-buy-now/?src=A00220><strong>investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should ...</p>\n\n<a href=\"https://www.investors.com/research/tilray-stock-buy-now/?src=A00220\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TLRY","symbol_name":"Tilray Inc.","start_time":0,"source_url":"https://www.investors.com/research/tilray-stock-buy-now/?src=A00220","article_id":"1193186975","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193186975","pubTimestamp":1626332296,"sourceInfo":{"source_id":"lsy1610449120050","name":"Investors"},"weMediaInfo":null,"summary":"Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TLRY":"Tilray Inc."},"translate_title":"参议员公布立法草案时，Tilray股票是买进吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TLRY":0.9},"content_text":"Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should you buy TLRY stock now?\nThe deal gives the combined company a market value approaching that of Canopy Growth(CGC), currently the largest pot stock. Tilray, post-merger, has a market cap of around $6.7 billion, according to Marketsmith. Canopy's market value is around $7.9 billion.\nAlong with their recreational businesses in Canada, the merger gives the combined company the old Tilray's medical business in Europe and Australia — as well as its debt. It also folds in Aphria's pharmaceutical distribution business, which, rather than cannabis, had driven a majority of Aphria's sales.\nThe deal also brings together a handful of U.S. businesses: Manitoba Harvest, a company owned by the old Tilray that sells hemp granola and CBD products, and SweetWater, \"a leading cannabis lifestyle branded craft brewer\" owned by Aphria.\nSome analysts have questioned whether that infrastructure would be enough to capture more business in THC products, should the U.S. legalize cannabis on a federal level.\nDemocratic Sens. Chuck Schumer, Ron Wyden and Cory Booker this week announced the release of draft legislation intended to end federal cannabis prohibition and open up financial access to cannabis businesses. But Canadian entry into the U.S., if it's ever allowed, won't be easy.\nMeanwhile, CEO Irwin Simon has asked shareholders to support a proposal allowing it authorize additional shares, a move it said would boost growth.\nSimon, in a letter to shareholders, said the proposal \"would authorize additional shares of our common stock so that we can move quickly to accelerate growth through potential acquisition and financing opportunities.\"\nApproving that proposal didn't mean those shares would be issued, he said. They would only be available if needed to pursue those goals.\nSimon recently told CNBC he \"absolutely\" welcomed the retail traders that have launched shares of the pot producer and those of GameStop(GME) and AMC Entertainment(AMC) higher this year.\nBelow, we take a closer look at TLRY stock.\nTLRY Stock Fundamental Analysis\nEarnings growth is a staple of top stocks. But the EPS Rating of TLRY stock stands at 29, with 99 being the best possible. Othermarijuana stocksalso have not-great profit ratings, as they continue to lose money. The EPS Rating is a gauge of a company's profit growth.\nTheComposite Ratingof TLRY stock stands at 34, according toMarketsmith chart analysis. IBD research says investors should focus on stocks with Composite Ratings of 90 or higher.\nAnalysts expect Tilray to lose money through this fiscal year and the next one. The company'sSMR Rating— or Sales + Margins + Return on Equity rating — is a weak E. The rating tallies the past three quarters of sales growth, pretax and after-tax profit margins and return on equity.\nTilray Stock Technical Analysis\nTLRY stock began trading in July 2018 on the Nasdaq via an IPO. That IPO was the first on a big U.S. exchange from a pure-play cannabis company.\nBut the stock largely fell between then and September of last year, after industrywide concerns about profitability, sales growth and cash grew more severe.\nThis year, shares soared as much as 711%, hitting 67 on Feb. 10. The stock is off those levels, and recently lost support at its 50-day line. Shares are not in a buy zone, and no new base pattern has formed.\nIs Tilray Stock A Buy?\nShares of Tilray are not in a base or in buy range. So TLRY stock is not a buy right now.\nIBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":147805073,"gmtCreate":1626347110992,"gmtModify":1703758340260,"author":{"id":"3582768244119565","authorId":"3582768244119565","name":"chichi000","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3582768244119565","authorIdStr":"3582768244119565"},"htmlText":"Done","listText":"Done","text":"Done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/147805073","repostId":1193186975,"repostType":4,"repost":{"id":"1193186975","pubTimestamp":1626332296,"share":"https://ttm.financial/m/news/1193186975?lang=&edition=fundamental","pubTime":"2021-07-15 14:58","market":"us","language":"en","title":"Is Tilray Stock A Buy As Senators Unveil Draft Legislation?","url":"https://stock-news.laohu8.com/highlight/detail?id=1193186975","media":"investors","summary":"Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U","content":"<p>Canadian pot producer&nbsp;<b>Tilray</b>(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform.&nbsp;So should you buy TLRY stock now?</p>\n<p>The deal gives the combined company a&nbsp;market value approaching that of&nbsp;<b>Canopy Growth</b>(CGC), currently the largest pot stock.&nbsp;Tilray, post-merger, has a market cap of around $6.7 billion, according to Marketsmith. Canopy's market value is around $7.9 billion.</p>\n<p>Along with their recreational businesses in Canada, the merger gives the combined company the old Tilray's medical business in Europe and Australia — as well as its debt. It also folds in Aphria's pharmaceutical distribution business, which, rather than cannabis, had driven a majority of Aphria's sales.</p>\n<p>The deal also brings together a handful of U.S. businesses: Manitoba Harvest, a company owned by the old Tilray that sells hemp granola and CBD products, and SweetWater, \"a leading cannabis lifestyle branded craft brewer\" owned by Aphria.</p>\n<p>Some analysts have questioned whether that infrastructure would be enough to capture more business in THC products, should the U.S. legalize cannabis on a federal level.</p>\n<p>Democratic Sens. Chuck Schumer, Ron Wyden and Cory Booker this week announced the release of draft legislation intended to end federal cannabis prohibition and open up financial access to cannabis businesses.&nbsp;But Canadian entry into the U.S., if it's ever allowed, won't be easy.</p>\n<p>Meanwhile, CEO Irwin Simon has asked shareholders to support a proposal allowing it authorize additional shares, a move it said would boost growth.</p>\n<p>Simon, in a letter to shareholders, said the proposal \"would authorize additional shares of our common stock so that we can move quickly to accelerate growth through potential acquisition and financing opportunities.\"</p>\n<p>Approving that proposal didn't mean those shares would be issued, he said. They would only be available if needed to pursue those goals.</p>\n<p>Simon recently&nbsp;told CNBC&nbsp;he \"absolutely\" welcomed the retail traders that have launched shares of the pot producer and those of&nbsp;<b>GameStop</b>(GME) and&nbsp;<b>AMC Entertainment</b>(AMC) higher this year.</p>\n<p>Below, we take a closer look at TLRY stock.</p>\n<p><b>TLRY Stock Fundamental Analysis</b></p>\n<p>Earnings growth is a staple of top stocks. But the&nbsp;EPS Rating&nbsp;of TLRY stock stands at 29, with 99 being the best possible. Othermarijuana stocksalso have not-great profit ratings, as they continue to lose money. The EPS Rating is a gauge of a company's profit growth.</p>\n<p>TheComposite Ratingof TLRY stock stands at 34, according toMarketsmith chart analysis.&nbsp;IBD research says investors should focus on stocks with Composite Ratings of 90 or higher.</p>\n<p>Analysts expect Tilray to lose money through this fiscal year and the next one. The company'sSMR Rating— or&nbsp;Sales + Margins + Return on Equity rating — is a weak E. The rating tallies the past three quarters of sales growth, pretax and after-tax profit margins and return on equity.</p>\n<p><b>Tilray Stock Technical Analysis</b></p>\n<p>TLRY stock began trading in July 2018 on the Nasdaq via an IPO. That IPO was the first on a big U.S. exchange from a pure-play cannabis company.</p>\n<p>But the stock largely fell between then and September of last year, after industrywide concerns about profitability, sales growth and cash grew more severe.</p>\n<p>This year, shares soared as much as 711%, hitting 67 on Feb. 10. The stock is off those levels, and recently lost support at its 50-day line. Shares are not in a buy zone, and no new base pattern has formed.</p>\n<p><b>Is Tilray Stock A Buy?</b></p>\n<p>Shares of Tilray are not in a base or in&nbsp;buy range.&nbsp;So TLRY stock is not a buy right now.</p>\n<p>IBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Tilray Stock A Buy As Senators Unveil Draft Legislation?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Tilray Stock A Buy As Senators Unveil Draft Legislation?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-15 14:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/research/tilray-stock-buy-now/?src=A00220><strong>investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should ...</p>\n\n<a href=\"https://www.investors.com/research/tilray-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://www.investors.com/research/tilray-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193186975","content_text":"Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should you buy TLRY stock now?\nThe deal gives the combined company a market value approaching that of Canopy Growth(CGC), currently the largest pot stock. Tilray, post-merger, has a market cap of around $6.7 billion, according to Marketsmith. Canopy's market value is around $7.9 billion.\nAlong with their recreational businesses in Canada, the merger gives the combined company the old Tilray's medical business in Europe and Australia — as well as its debt. It also folds in Aphria's pharmaceutical distribution business, which, rather than cannabis, had driven a majority of Aphria's sales.\nThe deal also brings together a handful of U.S. businesses: Manitoba Harvest, a company owned by the old Tilray that sells hemp granola and CBD products, and SweetWater, \"a leading cannabis lifestyle branded craft brewer\" owned by Aphria.\nSome analysts have questioned whether that infrastructure would be enough to capture more business in THC products, should the U.S. legalize cannabis on a federal level.\nDemocratic Sens. Chuck Schumer, Ron Wyden and Cory Booker this week announced the release of draft legislation intended to end federal cannabis prohibition and open up financial access to cannabis businesses. But Canadian entry into the U.S., if it's ever allowed, won't be easy.\nMeanwhile, CEO Irwin Simon has asked shareholders to support a proposal allowing it authorize additional shares, a move it said would boost growth.\nSimon, in a letter to shareholders, said the proposal \"would authorize additional shares of our common stock so that we can move quickly to accelerate growth through potential acquisition and financing opportunities.\"\nApproving that proposal didn't mean those shares would be issued, he said. They would only be available if needed to pursue those goals.\nSimon recently told CNBC he \"absolutely\" welcomed the retail traders that have launched shares of the pot producer and those of GameStop(GME) and AMC Entertainment(AMC) higher this year.\nBelow, we take a closer look at TLRY stock.\nTLRY Stock Fundamental Analysis\nEarnings growth is a staple of top stocks. But the EPS Rating of TLRY stock stands at 29, with 99 being the best possible. Othermarijuana stocksalso have not-great profit ratings, as they continue to lose money. The EPS Rating is a gauge of a company's profit growth.\nTheComposite Ratingof TLRY stock stands at 34, according toMarketsmith chart analysis. IBD research says investors should focus on stocks with Composite Ratings of 90 or higher.\nAnalysts expect Tilray to lose money through this fiscal year and the next one. The company'sSMR Rating— or Sales + Margins + Return on Equity rating — is a weak E. The rating tallies the past three quarters of sales growth, pretax and after-tax profit margins and return on equity.\nTilray Stock Technical Analysis\nTLRY stock began trading in July 2018 on the Nasdaq via an IPO. That IPO was the first on a big U.S. exchange from a pure-play cannabis company.\nBut the stock largely fell between then and September of last year, after industrywide concerns about profitability, sales growth and cash grew more severe.\nThis year, shares soared as much as 711%, hitting 67 on Feb. 10. The stock is off those levels, and recently lost support at its 50-day line. Shares are not in a buy zone, and no new base pattern has formed.\nIs Tilray Stock A Buy?\nShares of Tilray are not in a base or in buy range. So TLRY stock is not a buy right now.\nIBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":147339628,"gmtCreate":1626333285364,"gmtModify":1703758076822,"author":{"id":"3574633082610158","authorId":"3574633082610158","name":"AventadorKK","avatar":"https://static.tigerbbs.com/35568f4be027781afbf628f95c8f7627","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574633082610158","authorIdStr":"3574633082610158"},"htmlText":"Done","listText":"Done","text":"Done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/147339628","repostId":1193186975,"repostType":4,"repost":{"id":"1193186975","pubTimestamp":1626332296,"share":"https://ttm.financial/m/news/1193186975?lang=&edition=fundamental","pubTime":"2021-07-15 14:58","market":"us","language":"en","title":"Is Tilray Stock A Buy As Senators Unveil Draft Legislation?","url":"https://stock-news.laohu8.com/highlight/detail?id=1193186975","media":"investors","summary":"Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U","content":"<p>Canadian pot producer&nbsp;<b>Tilray</b>(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform.&nbsp;So should you buy TLRY stock now?</p>\n<p>The deal gives the combined company a&nbsp;market value approaching that of&nbsp;<b>Canopy Growth</b>(CGC), currently the largest pot stock.&nbsp;Tilray, post-merger, has a market cap of around $6.7 billion, according to Marketsmith. Canopy's market value is around $7.9 billion.</p>\n<p>Along with their recreational businesses in Canada, the merger gives the combined company the old Tilray's medical business in Europe and Australia — as well as its debt. It also folds in Aphria's pharmaceutical distribution business, which, rather than cannabis, had driven a majority of Aphria's sales.</p>\n<p>The deal also brings together a handful of U.S. businesses: Manitoba Harvest, a company owned by the old Tilray that sells hemp granola and CBD products, and SweetWater, \"a leading cannabis lifestyle branded craft brewer\" owned by Aphria.</p>\n<p>Some analysts have questioned whether that infrastructure would be enough to capture more business in THC products, should the U.S. legalize cannabis on a federal level.</p>\n<p>Democratic Sens. Chuck Schumer, Ron Wyden and Cory Booker this week announced the release of draft legislation intended to end federal cannabis prohibition and open up financial access to cannabis businesses.&nbsp;But Canadian entry into the U.S., if it's ever allowed, won't be easy.</p>\n<p>Meanwhile, CEO Irwin Simon has asked shareholders to support a proposal allowing it authorize additional shares, a move it said would boost growth.</p>\n<p>Simon, in a letter to shareholders, said the proposal \"would authorize additional shares of our common stock so that we can move quickly to accelerate growth through potential acquisition and financing opportunities.\"</p>\n<p>Approving that proposal didn't mean those shares would be issued, he said. They would only be available if needed to pursue those goals.</p>\n<p>Simon recently&nbsp;told CNBC&nbsp;he \"absolutely\" welcomed the retail traders that have launched shares of the pot producer and those of&nbsp;<b>GameStop</b>(GME) and&nbsp;<b>AMC Entertainment</b>(AMC) higher this year.</p>\n<p>Below, we take a closer look at TLRY stock.</p>\n<p><b>TLRY Stock Fundamental Analysis</b></p>\n<p>Earnings growth is a staple of top stocks. But the&nbsp;EPS Rating&nbsp;of TLRY stock stands at 29, with 99 being the best possible. Othermarijuana stocksalso have not-great profit ratings, as they continue to lose money. The EPS Rating is a gauge of a company's profit growth.</p>\n<p>TheComposite Ratingof TLRY stock stands at 34, according toMarketsmith chart analysis.&nbsp;IBD research says investors should focus on stocks with Composite Ratings of 90 or higher.</p>\n<p>Analysts expect Tilray to lose money through this fiscal year and the next one. The company'sSMR Rating— or&nbsp;Sales + Margins + Return on Equity rating — is a weak E. The rating tallies the past three quarters of sales growth, pretax and after-tax profit margins and return on equity.</p>\n<p><b>Tilray Stock Technical Analysis</b></p>\n<p>TLRY stock began trading in July 2018 on the Nasdaq via an IPO. That IPO was the first on a big U.S. exchange from a pure-play cannabis company.</p>\n<p>But the stock largely fell between then and September of last year, after industrywide concerns about profitability, sales growth and cash grew more severe.</p>\n<p>This year, shares soared as much as 711%, hitting 67 on Feb. 10. The stock is off those levels, and recently lost support at its 50-day line. Shares are not in a buy zone, and no new base pattern has formed.</p>\n<p><b>Is Tilray Stock A Buy?</b></p>\n<p>Shares of Tilray are not in a base or in&nbsp;buy range.&nbsp;So TLRY stock is not a buy right now.</p>\n<p>IBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Tilray Stock A Buy As Senators Unveil Draft Legislation?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Tilray Stock A Buy As Senators Unveil Draft Legislation?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-15 14:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/research/tilray-stock-buy-now/?src=A00220><strong>investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should ...</p>\n\n<a href=\"https://www.investors.com/research/tilray-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://www.investors.com/research/tilray-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193186975","content_text":"Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should you buy TLRY stock now?\nThe deal gives the combined company a market value approaching that of Canopy Growth(CGC), currently the largest pot stock. Tilray, post-merger, has a market cap of around $6.7 billion, according to Marketsmith. Canopy's market value is around $7.9 billion.\nAlong with their recreational businesses in Canada, the merger gives the combined company the old Tilray's medical business in Europe and Australia — as well as its debt. It also folds in Aphria's pharmaceutical distribution business, which, rather than cannabis, had driven a majority of Aphria's sales.\nThe deal also brings together a handful of U.S. businesses: Manitoba Harvest, a company owned by the old Tilray that sells hemp granola and CBD products, and SweetWater, \"a leading cannabis lifestyle branded craft brewer\" owned by Aphria.\nSome analysts have questioned whether that infrastructure would be enough to capture more business in THC products, should the U.S. legalize cannabis on a federal level.\nDemocratic Sens. Chuck Schumer, Ron Wyden and Cory Booker this week announced the release of draft legislation intended to end federal cannabis prohibition and open up financial access to cannabis businesses. But Canadian entry into the U.S., if it's ever allowed, won't be easy.\nMeanwhile, CEO Irwin Simon has asked shareholders to support a proposal allowing it authorize additional shares, a move it said would boost growth.\nSimon, in a letter to shareholders, said the proposal \"would authorize additional shares of our common stock so that we can move quickly to accelerate growth through potential acquisition and financing opportunities.\"\nApproving that proposal didn't mean those shares would be issued, he said. They would only be available if needed to pursue those goals.\nSimon recently told CNBC he \"absolutely\" welcomed the retail traders that have launched shares of the pot producer and those of GameStop(GME) and AMC Entertainment(AMC) higher this year.\nBelow, we take a closer look at TLRY stock.\nTLRY Stock Fundamental Analysis\nEarnings growth is a staple of top stocks. But the EPS Rating of TLRY stock stands at 29, with 99 being the best possible. Othermarijuana stocksalso have not-great profit ratings, as they continue to lose money. The EPS Rating is a gauge of a company's profit growth.\nTheComposite Ratingof TLRY stock stands at 34, according toMarketsmith chart analysis. IBD research says investors should focus on stocks with Composite Ratings of 90 or higher.\nAnalysts expect Tilray to lose money through this fiscal year and the next one. The company'sSMR Rating— or Sales + Margins + Return on Equity rating — is a weak E. The rating tallies the past three quarters of sales growth, pretax and after-tax profit margins and return on equity.\nTilray Stock Technical Analysis\nTLRY stock began trading in July 2018 on the Nasdaq via an IPO. That IPO was the first on a big U.S. exchange from a pure-play cannabis company.\nBut the stock largely fell between then and September of last year, after industrywide concerns about profitability, sales growth and cash grew more severe.\nThis year, shares soared as much as 711%, hitting 67 on Feb. 10. The stock is off those levels, and recently lost support at its 50-day line. Shares are not in a buy zone, and no new base pattern has formed.\nIs Tilray Stock A Buy?\nShares of Tilray are not in a base or in buy range. So TLRY stock is not a buy right now.\nIBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":147395479,"gmtCreate":1626333040391,"gmtModify":1703758070984,"author":{"id":"3565687171198207","authorId":"3565687171198207","name":"Holla","avatar":"https://static.tigerbbs.com/c0b0e402ff8043410cc67ffccbfe2174","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3565687171198207","authorIdStr":"3565687171198207"},"htmlText":"Like my comment pls","listText":"Like my comment pls","text":"Like my comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/147395479","repostId":1193186975,"repostType":4,"repost":{"id":"1193186975","pubTimestamp":1626332296,"share":"https://ttm.financial/m/news/1193186975?lang=&edition=fundamental","pubTime":"2021-07-15 14:58","market":"us","language":"en","title":"Is Tilray Stock A Buy As Senators Unveil Draft Legislation?","url":"https://stock-news.laohu8.com/highlight/detail?id=1193186975","media":"investors","summary":"Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U","content":"<p>Canadian pot producer&nbsp;<b>Tilray</b>(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform.&nbsp;So should you buy TLRY stock now?</p>\n<p>The deal gives the combined company a&nbsp;market value approaching that of&nbsp;<b>Canopy Growth</b>(CGC), currently the largest pot stock.&nbsp;Tilray, post-merger, has a market cap of around $6.7 billion, according to Marketsmith. Canopy's market value is around $7.9 billion.</p>\n<p>Along with their recreational businesses in Canada, the merger gives the combined company the old Tilray's medical business in Europe and Australia — as well as its debt. It also folds in Aphria's pharmaceutical distribution business, which, rather than cannabis, had driven a majority of Aphria's sales.</p>\n<p>The deal also brings together a handful of U.S. businesses: Manitoba Harvest, a company owned by the old Tilray that sells hemp granola and CBD products, and SweetWater, \"a leading cannabis lifestyle branded craft brewer\" owned by Aphria.</p>\n<p>Some analysts have questioned whether that infrastructure would be enough to capture more business in THC products, should the U.S. legalize cannabis on a federal level.</p>\n<p>Democratic Sens. Chuck Schumer, Ron Wyden and Cory Booker this week announced the release of draft legislation intended to end federal cannabis prohibition and open up financial access to cannabis businesses.&nbsp;But Canadian entry into the U.S., if it's ever allowed, won't be easy.</p>\n<p>Meanwhile, CEO Irwin Simon has asked shareholders to support a proposal allowing it authorize additional shares, a move it said would boost growth.</p>\n<p>Simon, in a letter to shareholders, said the proposal \"would authorize additional shares of our common stock so that we can move quickly to accelerate growth through potential acquisition and financing opportunities.\"</p>\n<p>Approving that proposal didn't mean those shares would be issued, he said. They would only be available if needed to pursue those goals.</p>\n<p>Simon recently&nbsp;told CNBC&nbsp;he \"absolutely\" welcomed the retail traders that have launched shares of the pot producer and those of&nbsp;<b>GameStop</b>(GME) and&nbsp;<b>AMC Entertainment</b>(AMC) higher this year.</p>\n<p>Below, we take a closer look at TLRY stock.</p>\n<p><b>TLRY Stock Fundamental Analysis</b></p>\n<p>Earnings growth is a staple of top stocks. But the&nbsp;EPS Rating&nbsp;of TLRY stock stands at 29, with 99 being the best possible. Othermarijuana stocksalso have not-great profit ratings, as they continue to lose money. The EPS Rating is a gauge of a company's profit growth.</p>\n<p>TheComposite Ratingof TLRY stock stands at 34, according toMarketsmith chart analysis.&nbsp;IBD research says investors should focus on stocks with Composite Ratings of 90 or higher.</p>\n<p>Analysts expect Tilray to lose money through this fiscal year and the next one. The company'sSMR Rating— or&nbsp;Sales + Margins + Return on Equity rating — is a weak E. The rating tallies the past three quarters of sales growth, pretax and after-tax profit margins and return on equity.</p>\n<p><b>Tilray Stock Technical Analysis</b></p>\n<p>TLRY stock began trading in July 2018 on the Nasdaq via an IPO. That IPO was the first on a big U.S. exchange from a pure-play cannabis company.</p>\n<p>But the stock largely fell between then and September of last year, after industrywide concerns about profitability, sales growth and cash grew more severe.</p>\n<p>This year, shares soared as much as 711%, hitting 67 on Feb. 10. The stock is off those levels, and recently lost support at its 50-day line. Shares are not in a buy zone, and no new base pattern has formed.</p>\n<p><b>Is Tilray Stock A Buy?</b></p>\n<p>Shares of Tilray are not in a base or in&nbsp;buy range.&nbsp;So TLRY stock is not a buy right now.</p>\n<p>IBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Tilray Stock A Buy As Senators Unveil Draft Legislation?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Tilray Stock A Buy As Senators Unveil Draft Legislation?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-15 14:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/research/tilray-stock-buy-now/?src=A00220><strong>investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should ...</p>\n\n<a href=\"https://www.investors.com/research/tilray-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"https://www.investors.com/research/tilray-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193186975","content_text":"Canadian pot producer Tilray(TLRY) has merged with rival Aphria, a move that gives it a handful of U.S. businesses as Democrats in Washington try to move forward with legal cannabis reform. So should you buy TLRY stock now?\nThe deal gives the combined company a market value approaching that of Canopy Growth(CGC), currently the largest pot stock. Tilray, post-merger, has a market cap of around $6.7 billion, according to Marketsmith. Canopy's market value is around $7.9 billion.\nAlong with their recreational businesses in Canada, the merger gives the combined company the old Tilray's medical business in Europe and Australia — as well as its debt. It also folds in Aphria's pharmaceutical distribution business, which, rather than cannabis, had driven a majority of Aphria's sales.\nThe deal also brings together a handful of U.S. businesses: Manitoba Harvest, a company owned by the old Tilray that sells hemp granola and CBD products, and SweetWater, \"a leading cannabis lifestyle branded craft brewer\" owned by Aphria.\nSome analysts have questioned whether that infrastructure would be enough to capture more business in THC products, should the U.S. legalize cannabis on a federal level.\nDemocratic Sens. Chuck Schumer, Ron Wyden and Cory Booker this week announced the release of draft legislation intended to end federal cannabis prohibition and open up financial access to cannabis businesses. But Canadian entry into the U.S., if it's ever allowed, won't be easy.\nMeanwhile, CEO Irwin Simon has asked shareholders to support a proposal allowing it authorize additional shares, a move it said would boost growth.\nSimon, in a letter to shareholders, said the proposal \"would authorize additional shares of our common stock so that we can move quickly to accelerate growth through potential acquisition and financing opportunities.\"\nApproving that proposal didn't mean those shares would be issued, he said. They would only be available if needed to pursue those goals.\nSimon recently told CNBC he \"absolutely\" welcomed the retail traders that have launched shares of the pot producer and those of GameStop(GME) and AMC Entertainment(AMC) higher this year.\nBelow, we take a closer look at TLRY stock.\nTLRY Stock Fundamental Analysis\nEarnings growth is a staple of top stocks. But the EPS Rating of TLRY stock stands at 29, with 99 being the best possible. Othermarijuana stocksalso have not-great profit ratings, as they continue to lose money. The EPS Rating is a gauge of a company's profit growth.\nTheComposite Ratingof TLRY stock stands at 34, according toMarketsmith chart analysis. IBD research says investors should focus on stocks with Composite Ratings of 90 or higher.\nAnalysts expect Tilray to lose money through this fiscal year and the next one. The company'sSMR Rating— or Sales + Margins + Return on Equity rating — is a weak E. The rating tallies the past three quarters of sales growth, pretax and after-tax profit margins and return on equity.\nTilray Stock Technical Analysis\nTLRY stock began trading in July 2018 on the Nasdaq via an IPO. That IPO was the first on a big U.S. exchange from a pure-play cannabis company.\nBut the stock largely fell between then and September of last year, after industrywide concerns about profitability, sales growth and cash grew more severe.\nThis year, shares soared as much as 711%, hitting 67 on Feb. 10. The stock is off those levels, and recently lost support at its 50-day line. Shares are not in a buy zone, and no new base pattern has formed.\nIs Tilray Stock A Buy?\nShares of Tilray are not in a base or in buy range. So TLRY stock is not a buy right now.\nIBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5226998,"gmtCreate":1626335596081,"gmtModify":1663231004845,"authorId":3564694009382914,"author":{"id":3564694009382914,"idStr":"3564694009382914","authorId":3564694009382914,"name":"Stormdust23","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":147395479,"type":1,"supId":0,"prevId":0,"content":"Hi","text":"Hi","html":"Hi"},{"id":5226810,"gmtCreate":1626333297811,"gmtModify":1663231001138,"authorId":3574633082610158,"author":{"id":3574633082610158,"idStr":"3574633082610158","authorId":3574633082610158,"name":"AventadorKK","avatar":"https://static.tigerbbs.com/35568f4be027781afbf628f95c8f7627","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":147395479,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":18,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}